RAinfo.org

Health Canada wants your feedback on the draft Guidance for determining medical device application type.

The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between July 1 and 31. 2023. The next update is scheduled for October 2023.

The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to May 31, 2023. The next update of data is scheduled for early October, 2023.

Content: Product monograph updates: Third generation aromatase inhibitors: Arimidex (anastrozole), Aromasin (exemestane), and Femara (letrozole), Topamax (topiramate)

Guidance on the Amendments to the Food and Drugs Act: Guide to New Authorities was developed to help Health Canada implement the new authorities that came into force upon royal assent of Bill C-17, the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law)

The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to April 30, 2023. The next update of data is scheduled for early September, 2023.

The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between June 1 and 30. 2023. The next update is scheduled for September 2023.

Safety Brief: mRNA COVID-19 vaccines (Comirnaty and Spikevax) and the risk of heavy menstrual bleeding ; Notice of market authorization with conditions: Akeega (niraparib and abiraterone acetate)

The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to March 31, 2023. The next update of data is scheduled for early August, 2023.

The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between May 1 and 31. 2023. The next update is scheduled for August 2023.

Product monograph updates: Tafinlar and Mekinist; Instructions for use update: SpaceOAR System; Vaccine safety summary.

Information about the types of patient lifts (also called hoists), how to manage the risk of falls, and reporting a serious adverse event.

The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between April 1 and 30, 2023. The next update is scheduled for July 2023.

The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to February 28, 2023. The next update of data is scheduled for early July, 2023.